ArticlePharmaceuticals (Basel, Switzerland)2023

Mirogabalin Decreases Pain-like Behaviors by Inhibiting the Microglial/Macrophage Activation, p38MAPK Signaling, and Pronociceptive CCL2 and CCL5 Release in a Mouse Model of Neuropathic Pain.

Renata Zajączkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.